D

Dermata Therapeutics, Inc. (DRMA)

NCM – Real Time Price. Currency in USD

1.31

+0.23 (21.10%)

Market open: Aug 12, 2026, 11:13 AM EDT

1.61

+0.53 (49.06%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Dermata Therapeutics, Inc. (DRMA)

NCM – Real Time Price. Currency in USD

1.31

+0.23 (21.10%)

Market open: Aug 12, 2026, 11:13 AM EDT

1.61

+0.53 (49.06%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

Cost of goods sold

0

Gross Profit

0

Operating expenses (excl. COGS)

-8M

-13M

-8M

-10M

Operating Income

-8M

-13M

-8M

-10M

Non-operating income, total

215K

226K

247K

64K

Pretax income

-8M

-12M

-8M

-10M

Equity in earnings

0

Taxes

0

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-8M

-12M

-8M

-10M

Discontinued operations

0

Net income

-8M

-12M

-8M

-10M

Dilution adjustment

0

Preferred dividends

0

Search stocks

Dermata Therapeutics, Inc. (DRMA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Dermata Therapeutics, Inc. (DRMA)

Income Statement (Annual)